Mabion (WAR:MAB) Short-Term Capital Lease Obligation : zł1.6 Mil (As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Mabion Short-Term Capital Lease Obligation?

Mabion's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was zł1.6 Mil.

Mabion's quarterly Short-Term Capital Lease Obligation declined from Mar. 2024 (zł1.6 Mil) to Jun. 2024 (zł1.4 Mil) but then increased from Jun. 2024 (zł1.4 Mil) to Sep. 2024 (zł1.6 Mil).

Mabion's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (zł2.9 Mil) to Dec. 2022 (zł3.0 Mil) but then declined from Dec. 2022 (zł3.0 Mil) to Dec. 2023 (zł1.6 Mil).

Mabion Short-Term Capital Lease Obligation Historical Data

The historical data trend for Mabion's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mabion Short-Term Capital Lease Obligation Chart

Mabion Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

2.12

2.36

2.92

2.95

1.58

Mabion Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															1.92	1.58	1.62	1.42	1.60

Mabion Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Mabion Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Mabion's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Mabion Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mabion SA (WAR:MAB) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

272:Germany

Address

ul. Gen. Mariana Langiewicza 60, Konstantynow Lodzki, POL, 95-050

Website

https://www.mabion.eu

Mabion SA is a Polish biotechnology company focused on developing and launching modern biotechnology drugs based on monoclonal antibody technology. The drugs developed by the company are targeted treatments, characterized by the drug's ability to recognize the factor causing cancer and interact with this factor only. The company is working on the development of its main priority drug, referred to as the MabionCD20 drug. The therapeutic uses of MabionCD20 are for Non-Hodgkin's lymphoma, Leukemia, and Rheumatoid Arthritis.